Alexion to Discuss Key Pipeline Programs at Virtual Investor Day

Sept. 14, 2020 11:00 UTC



BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals Inc. (Nasdaq:ALXN) a biotechnology company focused in rare disease development and commercialization, today announced that the company will host a Virtual Investor Day on Tuesday, October 6th, 2020 from 8:00 a.m. to 12:00 p.m. ET. Management will highlight continued strategic advancement, including key pipeline opportunities and drivers of future growth.

An audio webcast of the presentation will be available live. More details will be available at leading up to the event. An archived version of the remarks will also be available through the Company’s website for a limited time following the conference.



Chris Stevo
Head of Investor Relations
(857) 338-9309

Megan Goulart
Executive Director, Corporate Communications
(857) 338-8634


Source: Alexion Pharmaceuticals

Back to news